 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
$ q+ I5 i( h; [8 ^ 4 e5 W' b' p7 r3 J) y6 x
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.' p: {; u+ e# g
! y- U% M6 V5 {$ X" `! |* h
BY THE EDMONTON JOURNAL FEBRUARY 16, 20071 h4 \, T% k k5 I
% u# {& \2 {& f; A$ U) L/ e
* s$ ]' O( ^- K6 E0 f" V. aEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
' ?# `% k& N3 g. C7 w
# b1 Q" ]- D# P/ @! ZThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."4 S/ G% g& D! j$ P$ G$ N$ M+ j/ P
5 Z" _ ~, \, u+ cThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.+ `, z6 O3 P, A6 K+ m' u8 Z. C
) A" t# m6 k3 P; w' m6 q4 dIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday." B2 |. _! Y; V4 S1 w
! S$ r* i- u( GIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.6 k5 F/ A. m( Y4 b9 \
5 |. I, S; P& A. v" n% ]: l6 _
"As a scientist, it's one of the highlights of my CAREER," Shan said.3 E% p2 G/ k$ B- w1 g N; J! b7 b
9 [! |; F0 S+ t3 \
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
+ r2 O9 j+ f8 n1 ? M. G% g
( B$ ~* q- ]( \0 x7 T: rIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
3 k% B( c c: H$ h4 o4 N" w' h, e+ c! C$ J8 H( ~0 C( J& J" ^
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.4 w% e1 `! l) b1 ^
! C- b5 [ i- j0 r# G6 W& |; CThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
2 G* l3 C0 K# o9 D9 d% j
% `1 B& M7 E3 P. e" H9 o5 ^9 c4 {9 s1 F! L! x
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
